Skip to main content
Top
Published in: Health Research Policy and Systems 1/2015

Open Access 01-12-2016 | Research

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh

Authors: Yot Teerawattananon, Sripen Tantivess, Inthira Yamabhai, Nattha Tritasavit, Damian G. Walker, Joshua T. Cohen, Peter J. Neumann

Published in: Health Research Policy and Systems | Issue 1/2015

Login to get access

Abstract

Background

Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include limited stakeholder awareness, resources and data availability, as well as the lack of capacity to conduct country-specific economic evaluations. This study aims to survey health policy experts’ opinions on barriers to use of cost-effectiveness data in these settings and to obtain their advice on how to make a new cost-per-DALY database being developed by Tufts Medical Center more relevant to LMICs. It also identifies the factors influencing transferability.

Methods

In-depth interviews were conducted with 32 participants, including policymakers, technical advisors, and researchers in Health Ministries, universities and non-governmental organisations in Bangladesh, India (New Delhi, Tamil Nadu and Karnataka) and Vietnam.

Results

The survey revealed that, in all settings, the use of cost-effectiveness information in policy development is lacking, owing to limited knowledge among policymakers and inadequate human resources with health economics expertise in the government sector. Furthermore, researchers in universities do not have close connections with health authorities. In India and Vietnam, the demand for evidence to inform coverage decisions tends to increase as the countries are moving towards universal health coverage. The informants in all countries argue that cost-effectiveness data are useful for decision-makers; however, most of them do not perform data searches by themselves but rely on the information provided by the technical advisor counterparts. Most interviewees were familiar with using evidence from other countries and were also aware of the influences of contextual elements as a limitation of transferability. Finally, strategies to promote the newly developed database include training on basic economic evaluation for policymakers and researchers, and effective communication programs, with support from reputable global agencies.

Conclusions

Although cost-effectiveness information is recognised as essential in resource allocation, there are several impediments in the generation and use of such evidence to inform priority setting in LMICs. As such, the Cost-per-DALY database should be well-designed and introduced with appropriate promotion strategies so that it will be helpful in real-world policymaking.
Appendix
Available only for authorised users
Footnotes
1
Generalisability is the degree to which the results of a study or systematic review can be extrapolated to other circumstances, in particular to routine healthcare situations.
 
2
Transferability is the ability to apply information and/or data from one setting to the user’s target setting and is dependent on context specificity.
 
3
A nominal value is an economic value expressed in historical nominal monetary terms while an international dollar is a value that has been adjusted and measured in terms of the Purchasing Power Parity.
 
4
A subjective rating score by reviewers from 1 (lowest quality) to 7 (highest quality). Scores reflect the following considerations (in order of importance): (1) whether or not the authors correctly computed the incremental cost-effectiveness ratios; (2) whether or not the authors comprehensively characterised the uncertainty of the results (see sensitivity analysis); (3) whether or not the authors correctly used and explicitly specified the health economic assumptions used in the study (e.g. discount rate, currency, time horizon); and (4) whether or not the authors appropriately and explicitly estimated the utility weights.
 
5
As part of the same project, we also conducted a parallel study using an electronic survey focusing on the usefulness and transferability of economic evaluation, which covers a range of countries in the Asian, African, and South American regions.
 
Literature
1.
go back to reference Balabanova D, Mills A, Conteh L, Akkazieva B, Banteyerga H, Dash U, Gilson L, Harmer A, Ibraimova A, Islam Z, et al. Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet. 2013;381(9883):2118–33.CrossRefPubMed Balabanova D, Mills A, Conteh L, Akkazieva B, Banteyerga H, Dash U, Gilson L, Harmer A, Ibraimova A, Islam Z, et al. Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet. 2013;381(9883):2118–33.CrossRefPubMed
2.
go back to reference Fischer KE. A systematic review of coverage decision-making on health technologies-evidence from the real world. Health Policy. 2012;107(2–3):218–30.CrossRefPubMed Fischer KE. A systematic review of coverage decision-making on health technologies-evidence from the real world. Health Policy. 2012;107(2–3):218–30.CrossRefPubMed
3.
go back to reference Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy. 1997;40(3):199–215.CrossRefPubMed Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy. 1997;40(3):199–215.CrossRefPubMed
4.
go back to reference Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy. 2000;52(3):179–92.CrossRefPubMed Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy. 2000;52(3):179–92.CrossRefPubMed
6.
go back to reference Pitt C, Goodman C, Hanson K. Economic evaluation in global perspective: a bibliometric analysis of the recent literature. London: London School of Hygiene & Tropical Medicine; 2015. Pitt C, Goodman C, Hanson K. Economic evaluation in global perspective: a bibliometric analysis of the recent literature. London: London School of Hygiene & Tropical Medicine; 2015.
7.
go back to reference Yothasamut J, Tantivess S, Teerawattananon Y. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health. 2009;12 Suppl 3:S26–30.CrossRefPubMed Yothasamut J, Tantivess S, Teerawattananon Y. Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health. 2009;12 Suppl 3:S26–30.CrossRefPubMed
8.
go back to reference Iglesias CP, Drummond MF, Rovira J, Group NP. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21(1):1–14.CrossRefPubMed Iglesias CP, Drummond MF, Rovira J, Group NP. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21(1):1–14.CrossRefPubMed
9.
go back to reference Chaikledkaew U, Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Tangcharoensathien V. The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand. Value Health. 2009;12 Suppl 3:S31–5.CrossRefPubMed Chaikledkaew U, Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Tangcharoensathien V. The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand. Value Health. 2009;12 Suppl 3:S31–5.CrossRefPubMed
10.
go back to reference Merlo G, Page K, Ratcliffe J, Halton K, Graves N. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2015;13(3):303–9.CrossRefPubMed Merlo G, Page K, Ratcliffe J, Halton K, Graves N. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2015;13(3):303–9.CrossRefPubMed
11.
go back to reference Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy. 2008;86(2–3):129–41.CrossRefPubMed Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy. 2008;86(2–3):129–41.CrossRefPubMed
12.
go back to reference Anell A. Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. Eur J Health Econ. 2004;5(1):28–35.CrossRefPubMed Anell A. Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. Eur J Health Econ. 2004;5(1):28–35.CrossRefPubMed
13.
go back to reference Kapol N, Maitreemit P, Chalongsuk R, Amrumpai Y, Sribundit N, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y. Making health technology assessment information available for decision making: the development of a Thai database. J Med Assoc Thai. 2008;91 Suppl 2:S8–10.PubMed Kapol N, Maitreemit P, Chalongsuk R, Amrumpai Y, Sribundit N, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y. Making health technology assessment information available for decision making: the development of a Thai database. J Med Assoc Thai. 2008;91 Suppl 2:S8–10.PubMed
14.
go back to reference Nixon J, Ulmann P, Glanville J, Boulenger S, Drummond M, de Pouvourville G. The European Network of Health Economic Evaluation Databases (EURO NHEED) Project. HEPAC. 2004;5(2):183–7.PubMed Nixon J, Ulmann P, Glanville J, Boulenger S, Drummond M, de Pouvourville G. The European Network of Health Economic Evaluation Databases (EURO NHEED) Project. HEPAC. 2004;5(2):183–7.PubMed
15.
go back to reference Nixon J, Stoykova B, Glanville J, Christie J, Drummond M, Kleijnen J. The U.K. NHS economic evaluation database. Int J Technol Assess Health Care. 2000;16(03):731–42.CrossRefPubMed Nixon J, Stoykova B, Glanville J, Christie J, Drummond M, Kleijnen J. The U.K. NHS economic evaluation database. Int J Technol Assess Health Care. 2000;16(03):731–42.CrossRefPubMed
16.
go back to reference Greenberg D, Rosen AB, Wacht O, Palmer J, Neumann PJ. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976–2006. Med Decis Making. 2010;30(3):320–7.CrossRefPubMed Greenberg D, Rosen AB, Wacht O, Palmer J, Neumann PJ. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976–2006. Med Decis Making. 2010;30(3):320–7.CrossRefPubMed
17.
go back to reference Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8.CrossRefPubMed Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8.CrossRefPubMed
18.
19.
go back to reference Airoldi M, Morton A. Adjusting life for quality or disability: stylistic difference or substantial dispute? Health Econ. 2009;18(11):1237–47.CrossRefPubMed Airoldi M, Morton A. Adjusting life for quality or disability: stylistic difference or substantial dispute? Health Econ. 2009;18(11):1237–47.CrossRefPubMed
20.
go back to reference Health Intervention and Technology Assessment Program (Thailand). A review of the evidence – many contexts, multiple methods, Methods for Economic Evaluation Project (MEEP). London: NICE International; 2014. Health Intervention and Technology Assessment Program (Thailand). A review of the evidence – many contexts, multiple methods, Methods for Economic Evaluation Project (MEEP). London: NICE International; 2014.
24.
go back to reference Adams AM, Ahmed T, El Arifeen S, Evans TG, Huda T, Reichenbach L. Innovation for universal health coverage in Bangladesh: a call to action. Lancet. 2013;382(9910):2104–11.CrossRefPubMed Adams AM, Ahmed T, El Arifeen S, Evans TG, Huda T, Reichenbach L. Innovation for universal health coverage in Bangladesh: a call to action. Lancet. 2013;382(9910):2104–11.CrossRefPubMed
26.
go back to reference Quibria MG. Aid Effectiveness in Bangladesh. Dhaka: Policy Research Institute of Bangladesh; 2010. Quibria MG. Aid Effectiveness in Bangladesh. Dhaka: Policy Research Institute of Bangladesh; 2010.
27.
go back to reference Somanathan A, Tandon A, Huong L, Hurt K, Fuenzalida-Puelma H. Moving toward Universal Coverage of Social Health Insurance in Vietnam. Washington DC: World Bank; 2014.CrossRef Somanathan A, Tandon A, Huong L, Hurt K, Fuenzalida-Puelma H. Moving toward Universal Coverage of Social Health Insurance in Vietnam. Washington DC: World Bank; 2014.CrossRef
28.
go back to reference Tran BX, Nong VM, Maher RM, Nguyen PK, Luu HN. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One. 2014;9(8):e103825.CrossRefPubMedPubMedCentral Tran BX, Nong VM, Maher RM, Nguyen PK, Luu HN. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One. 2014;9(8):e103825.CrossRefPubMedPubMedCentral
Metadata
Title
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
Authors
Yot Teerawattananon
Sripen Tantivess
Inthira Yamabhai
Nattha Tritasavit
Damian G. Walker
Joshua T. Cohen
Peter J. Neumann
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2015
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-016-0156-6

Other articles of this Issue 1/2015

Health Research Policy and Systems 1/2015 Go to the issue